Acknowledgements
No public or private funding was used in this study. We thank Ms. Junko Yokobori, Ms. Mika Ohki, and Ms. Yumi Kobayashi for their exceptional support of this study as clinical research coordinators. Ms. Eriko Takamine, a certified genetic counselor, helped to organize the Molecular Tumor Board and the genetic counseling of patients who had potential germline mutations. We would like to extend our gratitude to Ms. Tomomi Urata, Ms. Rieko Furuya, and Ms. Akiko Noguchi for their administrative support. Finally, we thank H. Nikki March, PhD, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.